Clinical Trials Logo

Clinical Trial Summary

Background. Enhanced Recovery After Surgery (E.R.A.S.) programs are now widely accepted in colonic laparoscopic resections because of faster recovery and less perioperative complications.

Objective. Aim of this study is to assess safety and feasibility of discharging patients operated on by laparoscopic colectomy on Post Operative Day 2 (POD 2), so long as the first flatus has passed and in the absence of complication-related symptoms.

Design & Settings. Non-inferiority, open-label, single center, prospective, randomized study comparing "Ultra" to Classic E.R.A.S. with discharge on POD 2 and 4 respectively.

Patients. 765 patients with resectable non metastatic colonic cancer were analyzed: 384 patients were assigned to "Ultra" E.R.A.S. and 381 to Classic E.R.A.S.

Main Outcome Measures. Demographics, clinico-pathological, ASA class and morbi-mortality, along with surgical complications, re-operation and readmission rate were recorded and compared. Primary end-point was mortality; secondary end-points were morbidity, re-admission and re-operation rate.

Limitations. It is a single center experience; it is not double-blind, with the intrinsic risk of intentional or unconscious bias; exclusion criteria because of "non compliance" may be considered arbitrary.


Clinical Trial Description

From January 2008 to September 2015, 765 patients were prospectively randomized for early discharge after laparoscopic colectomy according to E.R.A.S. programs: after obtained informed consent, 384 patients were randomly assigned to the "Ultra" E.R.A.S. group and 381 to Classic E.R.A.S. group. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02727153
Study type Interventional
Source AUSL Romagna Rimini
Contact
Status Completed
Phase Phase 3
Start date January 2008
Completion date December 2015

See also
  Status Clinical Trial Phase
Completed NCT01339273 - Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection N/A
Terminated NCT02585271 - Transanal Decompression Tube Versus Stent for Acute Malignant Left-sided Colonic and Rectal Obstruction N/A
Completed NCT06426745 - Split-dose Versus Single-dose Bowel Preparation for Colonoscopy N/A
Completed NCT00938210 - Rehabilitation Following Laparoscopic Colonic Surgery N/A
Recruiting NCT05133544 - Endocuff With or Without AI-assisted Colonoscopy N/A
Recruiting NCT03803891 - Endoscopic Full-Thickness Resection In Colon
Completed NCT03130166 - INtracorporeal Versus EXtracorporeal Anastomosis in Robotic Right Colectomy N/A
Completed NCT00280332 - A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy N/A
Completed NCT03139942 - Optical Polyp Testing for In Vivo Classification N/A
Active, not recruiting NCT03446157 - Palbociclib and Cetuximab in Metastatic Colorectal Cancer Phase 2
Recruiting NCT03355495 - R vs L Lateral Decubitus Positioning in Colonoscopy N/A
Recruiting NCT04906343 - Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia N/A
Recruiting NCT04185272 - Butyrophilins Role in Colon Cancer N/A
Not yet recruiting NCT05303818 - Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer Phase 4
Completed NCT04683783 - National Registry of Liver First Approach
Recruiting NCT03033719 - Colectomy for Cancer in the Elderly by Laparoscopy or Laparotomy N/A
Recruiting NCT04316013 - Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial Phase 3
Completed NCT04434508 - Open Versus Laparoscopic Right Hemicolectomy for Right Colon Cancer N/A
Completed NCT01287130 - AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Phase 1
Completed NCT00427492 - Effect of Postoperative Laxative on Bowel Function After Colonic Surgery Phase 4